The IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h
of acute ischaemic stroke (the third international stroke trial ): a randomised controlled trial. Lancet 2012; 379: 2352-63—In this Article
(June 23), the affiliations for two members of the writing committee were incorrect. Anna Czlonkowska's affiliations should have been
“Institute of Psychiatry and Neurology, Warsaw, Poland, and Medical University of Warsaw, Warsaw, Poland”. Adam Kobayashi's affiliation
should have been “Institute of Psychiatry and Neurology, Warsaw, Poland”. These corrections have been made to the online version as of Aug
24, 2012.
